Feifei Yuan Selected Research

IC 261

12/2020

IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feifei Yuan Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 01/2019
2	Inflammation (Inflammations) 01/2022 - 04/2014
2	Carcinogenesis 01/2021 - 01/2019
1	Sarcopenia 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Arrest of spermatogenesis 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 12/2020
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Weight Loss (Weight Reduction) 04/2014
1	Overweight 04/2014
1	Dyslipidemias (Dyslipidemia) 11/2013

Drug/Important Bio-Agent (IBA)

1	neohesperidinIBA 01/2022
1	EucalyptolIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	beta-eudesmolIBA 01/2022
1	anonaineIBA 01/2022
1	magnololIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	honokiolIBA 01/2022
1	obovatolIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2021
1	CreatinineIBA 01/2021
1	IC 261IBA 12/2020
1	Protein Isoforms (Isoforms)IBA 12/2020
1	Casein Kinase I (Casein Kinase 1)IBA 12/2020
1	Biological ProductsIBA 04/2020
1	CateninsIBA 01/2019
1	IronIBA 04/2014
1	CholesterolIBA 11/2013
1	CalciumIBA 11/2013
1	LipidsIBA 11/2013

Therapy/Procedure

2	Therapeutics 01/2022 - 12/2020
1	Operative Time 01/2021
1	Nephrectomy 01/2021
1	Intraperitoneal Injections 12/2020